ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients

[1]  J. Griffith,et al.  Clinical Features of Emergency Department Patients Presenting with Symptoms Suggestive of Acute Cardiac Ischemia: A Multicenter Study , 1998, Journal of Thrombosis and Thrombolysis.

[2]  K. Swedberg,et al.  Buccal versus intravenous nitroglyerin in unstable angina pectoris , 2004, European Journal of Clinical Pharmacology.

[3]  Pamela S Douglas,et al.  Acc/aha/ase 2003 Guideline Update for the Clinical Application of Echocardiography: Summary Article a Report of the American College of Cardiology/american Heart Association Task Force on Practice Guidelines (acc/aha/ase Committee to Update the 1997 Guidelines for the Clinical Application of Echocar , 2003 .

[4]  S. Marsch,et al.  A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary artery stents. , 2003, Journal of the American College of Cardiology.

[5]  H. White,et al.  Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes , 2002, The Lancet.

[6]  P. Serruys,et al.  Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial. , 2002, JAMA.

[7]  E. Braunwald,et al.  Estimating treatment effects from observational data: dissonant and resonant notes from the SYMPHONY trials. , 2002, JAMA.

[8]  E. Topol,et al.  Impact of Different Platelet Glycoprotein IIb/IIIa Receptor Inhibitors Among Diabetic Patients Undergoing Percutaneous Coronary Intervention: Do Tirofiban and ReoPro Give Similar Efficacy Outcomes Trial (TARGET) 1-Year Follow-Up , 2002, Circulation.

[9]  S. Yusuf,et al.  Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study ☆ , 2002 .

[10]  R. Califf,et al.  Long-term efficacy of platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention. , 2002, JAMA.

[11]  E. Antman,et al.  An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS. , 2002, European heart journal.

[12]  R. Califf,et al.  Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials , 2002, The Lancet.

[13]  勝又 直樹.  Enhanced myosin light chain phosphorylations as a central mechanism for coronary artery spasm in a swine model with interleukin-1β , 2002 .

[14]  P. Douglas.  Cardiovascular health and disease in women , 2002 .

[15]  P. Campbell.  Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes. , 2001, The New England journal of medicine.

[16]  E. Braunwald,et al.  Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial. , 2001, JAMA.

[17]  C. Vassanelli,et al.  [Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban]. , 2001, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology.

[18]  M. Ezekowitz,et al.  Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. , 2001, JAMA.

[19]  Salim Yusuf,et al.  Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study , 2001, The Lancet.

[20]  E. Topol,et al.  Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization. , 2001, The New England journal of medicine.

[21]  M. Simoons.  Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial , 2001, The Lancet.

[22]  G. Fonarow,et al.  In-hospital initiation of lipid-lowering therapy for patients with coronary heart disease: the time is now. , 2001, Circulation.

[23]  V. Hasselblad,et al.  Platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention: the ESPRIT trial: a randomized controlled trial. , 2001, JAMA.

[24]  C. Grines,et al.  Enoxaparin and abciximab adjunctive pharmacotherapy during percutaneous coronary intervention. , 2001, The Journal of invasive cardiology.

[25]  A. Gawlinski,et al.  Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP). , 2001, The American journal of cardiology.

[26]  K. Thygesen,et al.  Erratum: Myocardial infarction redefined - A consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction (Journal of the American College of Cardiology (2000) 36 (959-969)) , 2001 .

[27]  N. Kleiman,et al.  Dalteparin in combination with abciximab during percutaneous coronary intervention. , 2001, American heart journal.

[28]  G. Montalescot,et al.  Percutaneous Coronary Intervention After Subcutaneous Enoxaparin Pretreatment in Patients With Unstable Angina Pectoris , 2001, Circulation.

[29]  R. Califf,et al.  Therapeutic value of eptifibatide at community hospitals transferring patients to tertiary referral centers early after admission for acute coronary syndromes. PURSUIT Investigators. , 2001, Journal of the American College of Cardiology.

[30]  B. Horne,et al.  Usefulness of in-hospital prescription of statin agents after angiographic diagnosis of coronary artery disease in improving continued compliance and reduced mortality. , 2001, The American journal of cardiology.

[31]  L. Wallentin,et al.  Early statin treatment following acute myocardial infarction and 1-year survival. , 2001, JAMA.

[32]  P. R. R. Ecurrent,et al.  EFFECTS OF CLOPIDOGREL IN ADDITION TO ASPIRIN IN PATIENTS WITH ACUTE CORONARY SYNDROMES WITHOUT ST-SEGMENT ELEVATION , 2001 .

[33]  J. Mckenney,et al.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.

[34]  The Esprit investigators.  Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial , 2000, The Lancet.

[35]  H. Schultheiss,et al.  Beneficial effects of pravastatin (+/-colestyramine/niacin) initiated immediately after a coronary event (the randomized Lipid-Coronary Artery Disease [L-CAD] Study). , 2000, The American journal of cardiology.

[36]  Young Jj,et al.  Low-molecular-weight heparin therapy in percutaneous coronary intervention: the NICE 1 and NICE 4 trials. National Investigators Collaborating on Enoxaparin Investigators. , 2000 .

[37]  V. Fuster,et al.  Acute Antithrombotic Effect of a Front-Loaded Regimen of Clopidogrel in Patients With Atherosclerosis on Aspirin , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[38]  Hugo A. Katus,et al.  Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. , 2000, European heart journal.

[39]  J. W. Schaeffer,et al.  ACC/AHA guidelines for the management of patients with unstable angina and non–st-segment elevation myocardial infarction: A report of the american college of cardiology/ american heart association task force on practice guidelines (committee on the management of patients with unstable angina) , 2000 .

[40]  E. Antman,et al.  The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. , 2000, JAMA.

[41]  M. Bertrand,et al.  Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting : the clopidogrel aspirin stent international cooperative study (CLASSICS). , 2000, Circulation.

[42]  A. Skene,et al.  Oral glycoprotein IIb/IIIa inhibition with orbofiban in patients with unstable coronary syndromes (OPUS-TIMI 16) trial. , 2000, Circulation.

[43]  E. Braunwald,et al.  A classification of unstable angina revisited. , 2000, Circulation.

[44]  L. Wallentin,et al.  Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial , 2000, The Lancet.

[45]  C. Thalamas,et al.  Early potent antithrombotic effect with combined aspirin and a loading dose of clopidogrel on experimental arterial thrombogenesis in humans. , 2000, Circulation.

[46]  W R Bell,et al.  Thrombotic thrombocytopenic purpura associated with clopidogrel. , 2000, The New England journal of medicine.

[47]  E W Steyerberg,et al.  Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators. , 2000, Circulation.

[48]  R. Califf,et al.  Predictors of recurrent ischemic events and death in unstable coronary artery disease after treatment with combination antithrombotic therapy. , 2000, American heart journal.

[49]  Salim Yusuf,et al.  Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients , 2000, The Lancet.

[50]  P Serruys,et al.  Long-term treatment with a platelet glycoprotein-receptor antagonist after percutaneous coronary revascularization. EXCITE Trial Investigators. Evaluation of Oral Xemilofiban in Controlling Thrombotic Events. , 2000, The New England journal of medicine.

[51]  W. Weintraub,et al.  Eight-year mortality in the Emory Angioplasty versus Surgery Trial (EAST) , 2000, Journal of the American College of Cardiology.

[52]  H. Roskamm,et al.  A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary-artery stents. , 2000, Circulation.

[53]  E. Antman,et al.  Serum amyloid A predicts early mortality in acute coronary syndromes: A TIMI 11A substudy. , 2000, Journal of the American College of Cardiology.

[54]  R. Califf,et al.  Comparison of sibrafiban with aspirin for prevention of cardiovascular events after acute coronary syndromes: a randomised trial , 2000, The Lancet.

[55]  S. Yusuf,et al.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. , 2000 .

[56]  T. Wilt,et al.  Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol , 2000 .

[57]  C. Grines,et al.  Low-molecular-weight heparin therapy in percutaneous coronary intervention: the NICE 1 and NICE 4 trials. National Investigators Collaborating on Enoxaparin Investigators. , 2000, The Journal of invasive cardiology.

[58]  Ric,et al.  CARDIAC TROPONIN T LEVELS FOR RISK STRATIFICATION IN ACUTE MYOCARDIAL ISCHEMIA , 2000 .

[59]  R. Califf,et al.  Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial , 1999, The Lancet.

[60]  L. Deckelbaum,et al.  Combination therapy with tirofiban and enoxaparin in acute coronary syndromes. , 1999, International journal of cardiology.

[61]  Sonia S Anand,et al.  Oral anticoagulant therapy in patients with coronary artery disease: a meta-analysis. , 1999, JAMA.

[62]  H. White,et al.  Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban , 1999, The Lancet.

[63]  R. Califf,et al.  Platelet glycoprotein IIb/IIIa receptor inhibition in non-ST-elevation acute coronary syndromes: early benefit during medical treatment only, with additional protection during percutaneous coronary intervention. , 1999, Circulation.

[64]  R. Califf,et al.  Cardiogenic shock in patients with acute ischemic syndromes with and without ST-segment elevation. , 1999, Circulation.

[65]  V. Hasselblad,et al.  Clinical outcomes of bivalirudin for ischemic heart disease. , 1999, Circulation.

[66]  C. Cannon,et al.  Differences between men and women in the management of unstable angina pectoris (The GUARANTEE Registry). The GUARANTEE Investigators. , 1999, The American journal of cardiology.

[67]  E. Antman,et al.  Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial. , 1999, Circulation.

[68]  E. Antman,et al.  Assessment of the treatment effect of enoxaparin for unstable angina/non-Q-wave myocardial infarction. TIMI 11B-ESSENCE meta-analysis. , 1999, Circulation.

[69]  S. Snapinn,et al.  Intracoronary thrombus and platelet glycoprotein IIb/IIIa receptor blockade with tirofiban in unstable angina or non-Q-wave myocardial infarction. Angiographic results from the PRISM-PLUS trial (Platelet receptor inhibition for ischemic syndrome management in patients limited by unstable signs and s , 1999, Circulation.

[70]  J. Alpert,et al.  ACC/AHA guidelines for coronary artery bypass graft surgery , 1999 .

[71]  D Freimark,et al.  Acute myocardial infarction with isolated ST-segment elevation in posterior chest leads V7-9: "hidden" ST-segment elevations revealing acute posterior infarction. , 1999, Journal of the American College of Cardiology.

[72]  F. Ragmin.  Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study , 1999, The Lancet.

[73]  H. White,et al.  Four-year survival of patients with acute coronary syndromes without ST-segment elevation and prognostic significance of 0.5-mm ST-segment depression. , 1999, The American journal of cardiology.

[74]  T. Wilt,et al.  Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. , 1999, The New England journal of medicine.

[75]  J S Hochman,et al.  A new regimen for heparin use in acute coronary syndromes. , 1999, American heart journal.

[76]  E. Braunwald,et al.  Factors associated with failure of medical therapy in patients with unstable angina and non-Q wave myocardial infarction. A TIMI-IIIB database study. , 1999, European heart journal.

[77]  R. Califf,et al.  Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition in Stenting Investigators. , 1999, The New England journal of medicine.

[78]  C. Mannheimer,et al.  Clinical outcome of patients treated with spinal cord stimulation for therapeutically refractory angina pectoris , 1999, Heart.

[79]  B. Coller.  Potential non-glycoprotein IIb/IIIa effects of abciximab. , 1999, American heart journal.

[80]  B. Davis,et al.  Pravastatin prevents clinical events in revascularized patients with average cholesterol concentrations. Cholesterol and Recurrent Events CARE Investigators. , 1999, Journal of the American College of Cardiology.

[81]  W. Gibler,et al.  National Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for the use of cardiac markers in coronary artery diseases. , 1999, Clinical chemistry.

[82]  L. Køber,et al.  Effect of the angiotensin-converting enzyme inhibitor trandolapril on mortality and morbidity in diabetic patients with left ventricular dysfunction after acute myocardial infarction. Trace Study Group. , 1999, Journal of the American College of Cardiology.

[83]  C. Di Mario,et al.  Prevention of distal embolization during saphenous vein graft lesion angioplasty. Experience with a new temporary occlusion and aspiration system. , 1999, Circulation.

[84]  J. Tardif,et al.  Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes. The RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial. , 1999, Circulation.

[85]  R. Califf,et al.  Clinical significance of thrombocytopenia during a non-ST-elevation acute coronary syndrome. The platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial experience. , 1999, Circulation.

[86]  Sankey V. Williams,et al.  ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: executive summary and recommendations. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Chronic Stable Angina). , 1999, Circulation.

[87]  Conti Cr.  EECP-enhanced external counterpulsation. , 1999 .

[88]  R. Nesto,et al.  The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodes. , 1999, Journal of the American College of Cardiology.

[89]  P. Nourjah.  National Hospital Ambulatory Medical Care Survey: 1997 emergency department summary. , 1999 .

[90]  A. Garber,et al.  Cost-Effectiveness of Alternative Test Strategies for the Diagnosis of Coronary Artery Disease , 1999, Annals of Internal Medicine.

[91]  N. Reichek,et al.  Dobutamine stress echocardiography in women with chest pain. Pilot phase data from the National Heart, Lung and Blood Institute Women's Ischemia Syndrome Evaluation (WISE). , 1999, Journal of the American College of Cardiology.

[92]  J. Murray,et al.  ACC/AHA guidelines for coronary angiography. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Coronary Angiography). Developed in collaboration with the Society for Cardiac Angiography and Interventions. , 1999, Journal of the American College of Cardiology.

[93]  J. Zimmerman,et al.  Diagnostic marker cooperative study for the diagnosis of myocardial infarction. , 1999, Circulation.

[94]  M Zaninotto,et al.  Strategies for the early diagnosis of acute myocardial infarction using biochemical markers. , 1999, American journal of clinical pathology.

[95]  K. Song,et al.  Interaction of ACE Inhibitors and Aspirin in Patients with Congestive Heart Failure , 1999, The Annals of pharmacotherapy.

[96]  R. Califf,et al.  Prognostic value of the admission electrocardiogram in acute coronary syndromes. , 1999, JAMA.

[97]  R. Kuntz.  Importance of considering atherosclerosis progression when choosing a coronary revascularization strategy: the diabetes-percutaneous transluminal coronary angioplasty dilemma. , 1999, Circulation.

[98]  R. Califf,et al.  Coronary revascularization in diabetic patients: a comparison of the randomized and observational components of the Aypass Angioplasty Revascularization Investigation (BARI). , 1999, Circulation.

[99]  R. Califf,et al.  Effect of age on outcome with primary angioplasty versus thrombolysis. , 1999, Journal of the American College of Cardiology.

[100]  R H Christenson,et al.  Simultaneous rapid measurement of whole blood myoglobin, creatine kinase MB, and cardiac troponin I by the triage cardiac panel for detection of myocardial infarction. , 1999, Clinical chemistry.

[101]  Eric J Topol,et al.  Platelet GPIIb-IIIa blockers , 1999, The Lancet.

[102]  J. Ornato,et al.  Early diagnosis of acute myocardial infarction in patients without ST-segment elevation. , 1999, The American journal of cardiology.

[103]  E. Hannan,et al.  A comparison of three-year survival after coronary artery bypass graft surgery and percutaneous transluminal coronary angioplasty. , 1999, Journal of the American College of Cardiology.

[104]  L. Wallentin,et al.  Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study , 1999 .

[105]  C. Cannon,et al.  Critical Pathways for Acute Coronary Syndromes , 1999 .

[106]  L. Køber,et al.  Effect of the angiotensin-converting enzyme inhibitor trandolapril on mortality and morbidity in diabetic patients with left ventricular dysfunction after acute myocardial infarction. Trace Study Group. , 1999, Journal of the American College of Cardiology.

[107]  S. Kaul,et al.  ACC/AHA expert consensus document. Use of sildenafil (Viagra) in patients with cardiovascular disease. American College of Cardiology/American Heart Association. , 1999, Journal of the American College of Cardiology.

[108]  A. Wu,et al.  A comparison of cardiac troponin T and cardiac troponin I in patients with acute coronary syndromes. , 1999, Coronary artery disease.

[109]  M. Keltai,et al.  Comparison of two treatment durations (6 days and 14 days) of a low molecular weight heparin with a 6-day treatment of unfractionated heparin in the initial management of unstable angina or non-Q wave myocardial infarction: FRAX.I.S. (FRAxiparine in Ischaemic Syndrome). , 1999, European heart journal.

[110]  J. Eisenberg.  Agency for Health Care Policy and Research. , 1999, Medical care.

[111]  C. Conti.  EECP-enhanced external counterpulsation. , 1999, Journal of the American College of Cardiology.

[112]  R. Hendel,et al.  A randomized, multicenter trial of weight-adjusted intravenous heparin dose titration and point-of-care coagulation monitoring in hospitalized patients with active thromboembolic disease. Antithrombotic Therapy Consortium Investigators. , 1999, American heart journal.

[113]  L. Klein,et al.  Unstable angina and non-Q wave myocardial infarction: does the clinical diagnosis have therapeutic implications? , 1999, Journal of the American College of Cardiology.

[114]  F. Apple,et al.  Clinical and analytical standardization issues confronting cardiac troponin I. , 1999, Clinical chemistry.

[115]  R. Kleiger,et al.  Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators. , 1999, The New England journal of medicine.

[116]  D. Mark,et al.  The chest-pain unit--ready for prime time? , 1998, The New England journal of medicine.

[117]  David P Miller,et al.  Clinical outcomes of therapeutic agents that block the platelet glycoprotein IIb/IIIa integrin in ischemic heart disease. , 1998, Circulation.

[118]  F Rovelli,et al.  Ten-year follow-up of the first megatrial testing thrombolytic therapy in patients with acute myocardial infarction: results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto-1 study. The GISSI Investigators. , 1998, Circulation.

[119]  J P Ornato,et al.  Use of the Acute Cardiac Ischemia Time-Insensitive Predictive Instrument (ACI-TIPI) To Assist with Triage of Patients with Chest Pain or Other Symptoms Suggestive of Acute Cardiac Ischemia: A Multicenter, Controlled Clinical Trial , 1998, Annals of Internal Medicine.

[120]  M. Staal,et al.  Spinal cord stimulation in chronic intractable angina pectoris: a randomized, controlled efficacy study. , 1998, American heart journal.

[121]  E. Braunwald,et al.  Unstable angina: an etiologic approach to management. , 1998, Circulation.

[122]  E. DeLong,et al.  Value of exercise treadmill testing in women. , 1998, Journal of the American College of Cardiology.

[123]  R. Collins,et al.  Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. , 1998, The New England journal of medicine.

[124]  K. Lee,et al.  Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes. The GUSTO-IIa Investigators. , 1998, Circulation.

[125]  R. Fromm,et al.  Management of acute coronary syndromes based on risk stratification by biochemical markers: an idea whose time has come. , 1998, Circulation.

[126]  C. Bode,et al.  Induction of Fibrinogen Binding and Platelet Aggregation as a Potential Intrinsic Property of Various Glycoprotein IIb/IIIa (IIbβ3) Inhibitors , 1998 .

[127]  E. Ohman,et al.  Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. , 1998, Chest.

[128]  I. Chiappino,et al.  Prognostic implications of detection of troponin I in patients with unstable angina pectoris. , 1998, American Journal of Cardiology.

[129]  T. Feldman,et al.  Acute and late clinical outcome after rotational atherectomy for complex coronary disease. , 1998, Catheterization and cardiovascular diagnosis.

[130]  A. Jacobs,et al.  Better outcome for women compared with men undergoing coronary revascularization: a report from the bypass angioplasty revascularization investigation (BARI) , 1998, Circulation.

[131]  R. Jordan,et al.  Abciximab (ReoPro, Chimeric 7E3 Fab) Demonstrates Equivalent Affinity and Functional Blockade of Glycoprotein IIb/IIIa and αvβ3 Integrins , 1998 .

[132]  A. Rebuzzi,et al.  Incremental prognostic value of serum levels of troponin T and C-reactive protein on admission in patients with unstable angina pectoris. , 1998, The American journal of cardiology.

[133]  J. Pogue,et al.  Long-term oral anticoagulant therapy in patients with unstable angina or suspected non-Q-wave myocardial infarction: organization to assess strategies for ischemic syndromes (OASIS) pilot study results. , 1998, Circulation.

[134]  Philip D. Harvey,et al.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 , 1998, BMJ.

[135]  R. Holman,et al.  Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) , 1998, The Lancet.

[136]  W. O’Neill,et al.  A prospective randomized trial of triage angiography in acute coronary syndromes ineligible for thrombolytic therapy. Results of the medicine versus angiography in thrombolytic exclusion (MATE) trial. , 1998, Journal of the American College of Cardiology.

[137]  R. Makuch,et al.  Verapamil use in patients with cardiovascular disease: An overview of randomized trials , 1998, Clinical cardiology.

[138]  P. Théroux,et al.  Intravenous diltiazem in acute myocardial infarction. Diltiazem as adjunctive therapy to activase (DATA) trial. , 1998, Journal of the American College of Cardiology.

[139]  E. Vittinghoff,et al.  Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. , 1998, JAMA.

[140]  S. Yusuf,et al.  Variations between countries in invasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without initial ST elevation , 1998, The Lancet.

[141]  Uk-Prospective-Diabetes-Study-Group.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) , 1998, The Lancet.

[142]  M. Gent,et al.  Adverse Haematological Effects of Ticlopidine , 1998, Drug safety.

[143]  F. Fesmire,et al.  Serial creatinine kinase (CK) MB testing during the emergency department evaluation of chest pain: utility of a 2-hour deltaCK-MB of +1.6ng/ml. , 1998, American heart journal.

[144]  R. Califf,et al.  Occurrence and clinical significance of thrombocytopenia in a population undergoing high-risk percutaneous coronary revascularization. Evaluation of c7E3 for the Prevention of Ischemic Complications (EPIC) Study Group. , 1998, Journal of the American College of Cardiology.

[145]  M. Hadamitzky,et al.  Intracoronary stenting and risk for major adverse cardiac events during the first month. , 1998, Circulation.

[146]  T. Investigators.  Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. , 1998, Lancet.

[147]  C. White,et al.  Morphologic comparison of atherosclerotic lesions in native coronary arteries and saphenous vein graphs with intracoronary angioscopy in patients with unstable angina. , 1998, American heart journal.

[148]  J S Martin,et al.  Utility of the prehospital electrocardiogram in diagnosing acute coronary syndromes: the Myocardial Infarction Triage and Intervention (MITI) Project. , 1998, Journal of the American College of Cardiology.

[149]  J. Mcgraw,et al.  Textbook of Cardiovascular Medicine , 1998 .

[150]  R. Kleiger,et al.  Correction: Outcomes in Patients with Acute Non-Q-Wave Myocardial Infarction Randomly Assigned to an Invasive as Compared with a Conservative Management Strategy. , 1998, The New England journal of medicine.

[151]  D. Waters,et al.  Prognostic role of troponin T versus troponin I in unstable angina pectoris for cardiac events with meta-analysis comparing published studies. , 1998, The American journal of cardiology.

[152]  R. Collins,et al.  Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials. ACE Inhibitor Myocardial Infarction Collaborative Group. , 1998, Circulation.

[153]  E. Antman,et al.  C-Reactive Protein Is a Potent Predictor of Mortality Independently of and in Combination With Troponin T in Acute Coronary Syndromes: A TIMI 11A Substudy , 1998 .

[154]  E. Swahn,et al.  Unstable coronary artery disease in post-menopausal women. Identifying patients with significant coronary artery disease by basic clinical parameters and exercise test. IRIS Study Group. , 1998, European heart journal.

[155]  M. Simoons,et al.  Unstable angina: good long-term outcome after a complicated early course. , 1998, Journal of the American College of Cardiology.

[156]  David P Miller,et al.  Diabetes mellitus, glycoprotein IIb/IIIa blockade, and heparin: evidence for a complex interaction in a multicenter trial. EPILOG Investigators. , 1998, Circulation.

[157]  R. Califf,et al.  Economic assessment of low-molecular-weight heparin (enoxaparin) versus unfractionated heparin in acute coronary syndrome patients: results from the ESSENCE randomized trial. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q wave Coronary Events [unstable angina or non-Q-wave myocardial infarc , 1998, Circulation.

[158]  R. Collins,et al.  ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither , 1998, BMJ.

[159]  C. Camargo,et al.  Electrocardiographic and clinical predictors of acute myocardial infarction in patients with unstable angina pectoris. , 1998 .

[160]  A. Takeshita,et al.  Angina pectoris caused by coronary microvascular spasm , 1998, The Lancet.

[161]  H. Ostermann.  Low molecular weight heparins , 1998, Der Internist.

[162]  L. Hillis,et al.  Prinzmetal's variant angina , 1998, Clinical cardiology.

[163]  V. Fuster,et al.  Acute coronary syndromes: unstable angina and non-Q-wave myocardial infarction. , 1998, Circulation.

[164]  C. Naylor,et al.  Fifteen-year trends in risk severity and operative mortality in elderly patients undergoing coronary artery bypass graft surgery. , 1998, Circulation.

[165]  J. Hochman,et al.  Failure to Achieve Optimal Anticoagulation With Commonly Used Heparin Regimens; A Review of GUSTO II , 1998 .

[166]  K. Fox,et al.  Long-term prognosis in unstable angina. The importance of early risk stratification using continuous ST segment monitoring. , 1998, European heart journal.

[167]  David P Miller,et al.  Benefit of early sustained reperfusion in patients with prior myocardial infarction (the GUSTO-I trial). Global Utilization of Streptokinase and TPA for occluded arteries. , 1998, The American journal of cardiology.

[168]  E. Antman,et al.  Time to positivity of a rapid bedside assay for cardiac-specific troponin T predicts prognosis in acute coronary syndromes: a Thrombolysis in Myocardial Infarction (TIMI) 11A substudy. , 1998, Journal of the American College of Cardiology.

[169]  R. Califf,et al.  Myonecrosis after revascularization procedures. , 1998, Journal of the American College of Cardiology.

[170]  P Théroux,et al.  Platelet activation with unfractionated heparin at therapeutic concentrations and comparisons with a low-molecular-weight heparin and with a direct thrombin inhibitor. , 1998, Circulation.

[171]  Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. , 1998, The New England journal of medicine.

[172]  Gebhardt,et al.  International, randomized, controlled trial of lamifiban (a platelet glycoprotein IIb/IIIa inhibitor), heparin, or both in unstable angina , 1998 .

[173]  N. Danchin,et al.  Ticlopidine-aspirin as antithrombotic regimen for intracoronary stenting for unstable angina: is there a need for further antiplatelet therapy? , 1998 .

[174]  W. Weintraub,et al.  Long term outcome of patients with non Q-wave myocardial infarction with or without revascularization , 1998 .

[175]  E. Antman,et al.  C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction. , 1998, Journal of the American College of Cardiology.

[176]  A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. , 1998, The New England journal of medicine.

[177]  Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. , 1998, The New England journal of medicine.

[178]  N. Kleiman.  Pharmacology of the intravenous platelet receptor glycoprotein IIb-IIIa antagonists. , 1998, Coronary artery disease.

[179]  R. Califf,et al.  Does intracoronary thrombus influence the outcome of high risk percutaneous transluminal coronary angioplasty? Clinical and angiographic outcomes in a large multicenter trial. EPIC Investigators. Evaluation of IIb/IIIa Platelet Receptor Antagonist 7E3 in Preventing Ischemic Complications. , 1998, Journal of the American College of Cardiology.

[180]  E. Jones,et al.  Outcome of coronary bypass surgery versus coronary angioplasty in diabetic patients with multivessel coronary artery disease. , 1998, Journal of the American College of Cardiology.

[181]  G. Sanz,et al.  Short-term effects of transdermal estrogen replacement therapy on coronary vascular reactivity in postmenopausal women with angina pectoris and normal results on coronary angiograms. , 1998, Journal of the American College of Cardiology.

[182]  A. Takeshita,et al.  Enhanced myosin light chain phosphorylations as a central mechanism for coronary artery spasm in a swine model with interleukin-1beta. , 1997, Circulation.

[183]  C. Heeschen,et al.  Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. , 1997, The New England journal of medicine.

[184]  Coller Bs.  Monitoring platelet GP IIb/IIIa [corrected] antagonist therapy. , 1997 .

[185]  A. L'Abbate,et al.  Organic coronary stenosis in Prinzmetal's variant angina. , 1997, Journal of Cardiology.

[186]  R. Califf,et al.  Risk Stratification after Myocardial Infarction , 1997, Annals of Internal Medicine.

[187]  J. Moses,et al.  Influence of gender on in-hospital clinical and angiographic outcomes and on one-year follow-up in the New Approaches to Coronary Intervention (NACI) registry. , 1997, The American journal of cardiology.

[188]  P. Marino,et al.  Comparison of left ventricular function and volumes during transesophageal atrial pacing combined with two-dimensional echocardiography in patients with syndrome X, atherosclerotic coronary artery disease, and normal subjects. , 1997, The American journal of cardiology.

[189]  H. Spindola-Franco,et al.  Successful intracoronary thrombolysis in cocaine-associated acute myocardial infarction. , 1997, Catheterization and cardiovascular diagnosis.

[190]  S W Sharkey,et al.  Improved detection of minor ischemic myocardial injury with measurement of serum cardiac troponin I. , 1997, Clinical chemistry.

[191]  R. Califf,et al.  Relationship between diabetes mellitus and long-term survival after coronary bypass and angioplasty. , 1997, Circulation.

[192]  A. Jacobs,et al.  Documentation of decline in morbidity in women undergoing coronary angioplasty (a report from the 1993–1994 NHLBI Percutaneous Transluminal Coronary Angioplasty Registry) , 1997 .

[193]  D. Ardissino,et al.  C-reactive protein elevation and early outcome in patients with unstable angina pectoris. , 1997, The American journal of cardiology.

[194]  J. Hermiller,et al.  Comparison of six-month outcome of coronary artery stenting in patients <65, 65-75, and >75 years of age. , 1997, The American journal of cardiology.

[195]  T. B. Investigators,et al.  Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: the Bypass Angioplasty Revascularization Investigation (BARI) , 1997, Circulation.

[196]  M. Leon,et al.  Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. Saphenous Vein De Novo Trial Investigators. , 1997, The New England journal of medicine.

[197]  T. Investigators.  Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. The RESTORE Investigators. Randomized Efficacy Study of Tirofiban for Outcomes and REstenosis. , 1997, Circulation.

[198]  K. Nakao,et al.  Hyperventilation as a specific test for diagnosis of coronary artery spasm. , 1997, The American journal of cardiology.

[199]  M. Goggins,et al.  Elevated levels of circulating soluble adhesion molecules in peripheral blood of patients with unstable angina. , 1997, The American journal of cardiology.

[200]  L. Graff,et al.  Impact on the care of the emergency department chest pain patient from the chest pain evaluation registry (CHEPER) study. , 1997, The American journal of cardiology.

[201]  D. Phillips,et al.  Clinical pharmacology of eptifibatide. , 1997, The American journal of cardiology.

[202]  RITA-2 trial participants.  Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial , 1997, The Lancet.

[203]  M. Riggs,et al.  Usefulness of positive troponin-T and negative creatine kinase levels in identifying high-risk patients with unstable angina pectoris. , 1997, The American journal of cardiology.

[204]  R. Califf,et al.  A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group. , 1997 .

[205]  David P Miller,et al.  Long-term protection from myocardial ischemic events in a randomized trial of brief integrin beta3 blockade with percutaneous coronary intervention. EPIC Investigator Group. Evaluation of Platelet IIb/IIIa Inhibition for Prevention of Ischemic Complication. , 1997, JAMA.

[206]  H. Arendrup,et al.  Danish multicenter randomized study of invasive versus conservative treatment in patients with inducible ischemia after thrombolysis in acute myocardial infarction (DANAMI). DANish trial in Acute Myocardial Infarction. , 1997, Circulation.

[207]  I M Morison,et al.  Progression of the culprit lesion in unstable coronary artery disease with warfarin and aspirin versus aspirin alone: preliminary study. , 1997, Journal of the American College of Cardiology.

[208]  R. Califf,et al.  Evidence for prevention of death and myocardial infarction with platelet membrane glycoprotein IIb/IIIa receptor blockade by abciximab (c7E3 Fab) among patients with unstable angina undergoing percutaneous coronary revascularization. EPIC Investigators. Evaluation of 7E3 in Preventing Ischemic Compl , 1997, Journal of the American College of Cardiology.

[209]  C. Cannon,et al.  The electrocardiogram predicts one-year outcome of patients with unstable angina and non-Q wave myocardial infarction: results of the TIMI III Registry ECG Ancillary Study. Thrombolysis in Myocardial Ischemia. , 1997, Journal of the American College of Cardiology.

[210]  J. Cigarroa,et al.  Cocaine-induced myocardial ischemia and infarction: pathophysiology, recognition, and management. , 1997, Progress in cardiovascular diseases.

[211]  W. Klein,et al.  Comparison of low-molecular-weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease. Fragmin in unstable coronary artery disease study (FRIC) , 1997, Circulation.

[212]  E. Antman,et al.  ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). , 2002, Circulation.

[213]  Epilog Investigators,et al.  Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. , 1997, The New England journal of medicine.

[214]  A. Branzi,et al.  Results of coronary stenting for unstable versus stable angina pectoris. , 1997, The American journal of cardiology.

[215]  L. Wallentin,et al.  Risk stratification in unstable coronary artery disease. Additive value of troponin T determinations and pre-discharge exercise tests. FRISK Study Group. , 1997, European heart journal.

[216]  E. Antman,et al.  Detection of unsuspected myocardial necrosis by rapid bedside assay for cardiac troponin T. , 1997, American heart journal.

[217]  J. Ornato,et al.  The Physician's Role in Minimizing Prehospital Delay in Patients at High Risk for Acute Myocardial Infarction: Recommendations from the National Heart Attack Alert Program , 1997, Annals of Internal Medicine.

[218]  A. Jaffe,et al.  Prognostic influence of elevated values of cardiac troponin I in patients with unstable angina. , 1997, Circulation.

[219]  P. Ridker,et al.  Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. , 1997, The New England journal of medicine.

[220]  H. Krumholz,et al.  When to start cholesterol-lowering therapy in patients with coronary heart disease. A statement for healthcare professionals from the American Heart Association Task Force on Risk Reduction. , 1997, Circulation.

[221]  Richard P. Lewis,et al.  ACC/AHA Guidelines for the Clinical Application of Echocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography). Developed in collaboration with the American Society of Echocardio , 1997, Circulation.

[222]  R. Califf,et al.  Impact of Diabetes Mellitus on Percutaneous Revascularization (CAVEAT-I) , 1997 .

[223]  S. Fava,et al.  Outcome of Unstable Angina in Patients with Diabetes Mellitus , 1997, Diabetic medicine : a journal of the British Diabetic Association.

[224]  J. Herlitz,et al.  Morbidity and use of medical resources in patients with chest pain and normal or near-normal coronary arteries. , 1997, The American journal of cardiology.

[225]  D. Morrison,et al.  Coronary angioplasty for elderly patients with "high risk" unstable angina: short-term outcomes and long-term survival. , 1997, Journal of the American College of Cardiology.

[226]  D. Sane,et al.  Abciximab decreases both the incidence and magnitude of creatine kinase elevation during rotational atherectomy , 1997 .

[227]  H. Krumholz.  Organization to Assess Strategies for Ischemic Syndromes (OASIS). , 1997 .

[228]  J. Kupersmith,et al.  The pharmacologic management of heart disease , 1997 .

[229]  A. Jacobs,et al.  Documentation of decline in morbidity in women undergoing coronary angioplasty (a report from the 1993-94 NHLBI Percutaneous Transluminal Coronary Angioplasty Registry). National Heart, Lung, and Blood Institute. , 1997, The American journal of cardiology.

[230]  M D Hagen,et al.  An evaluation of technologies for identifying acute cardiac ischemia in the emergency department: a report from a National Heart Attack Alert Program Working Group. , 1997, Annals of emergency medicine.

[231]  Randomised placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT-II. Integrilin to Minimise Platelet Aggregation and Coronary Thrombosis-II. , 1997, Lancet.

[232]  B. Coller.  Monitoring platelet GP IIb/IIIa [corrected] antagonist therapy. , 1997, Circulation.

[233]  R. Jesse,et al.  Use of the combination of myoglobin and CK-MB mass for the rapid diagnosis of acute myocardial infarction. , 1997, The American journal of emergency medicine.

[234]  M. Bell,et al.  Comparison of immediate and long-term outcome of coronary angioplasty performed for unstable angina and rest pain in men and women. , 1997, Mayo Clinic proceedings.

[235]  D. Mark,et al.  ACC/AHA Guidelines for Exercise Testing. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). , 1997, Journal of the American College of Cardiology.

[236]  M. Whooley,et al.  Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina. A meta-analysis. , 1997, JAMA.

[237]  E. Braunwald,et al.  Results of percutaneous transluminal coronary angioplasty in unstable angina and non-Q-wave myocardial infarction. Observations from the TIMI IIIB Trial. , 1996, Circulation.

[238]  E. Topol,et al.  Cocaine-induced aortic dissection. , 1996, American heart journal.

[239]  P. Armstrong,et al.  Unstable angina--report from a Canadian expert roundtable. , 1996, The Canadian journal of cardiology.

[240]  D. Katz,et al.  The use of empiric clinical data in the evaluation of practice guidelines for unstable angina. , 1996, JAMA.

[241]  M. Dennis.  A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee , 1996 .

[242]  David Schultz,et al.  A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) , 1996, The Lancet.

[243]  P. Théroux,et al.  Angiographic features of vein grafts versus ungrafted coronary arteries in patients with unstable angina and previous bypass surgery. , 1996, Journal of the American College of Cardiology.

[244]  P. Poole‐Wilson,et al.  17-beta-Estradiol therapy lessens angina in postmenopausal women with syndrome X. , 1996, Journal of the American College of Cardiology.

[245]  Richard P. Lewis,et al.  ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). , 1996, Journal of the American College of Cardiology.

[246]  D Wybenga,et al.  Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. , 1996, The New England journal of medicine.

[247]  D. Faxon,et al.  Coronary angioplasty in diabetic patients. The National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. , 1996, Circulation.

[248]  K. Lee,et al.  Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-I trial. Global Utilization of Streptokinase and TPA for Occluded coronary arteries trial. , 1996, Circulation.

[249]  B. Davis,et al.  The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. , 1996, The New England journal of medicine.

[250]  M. Whooley,et al.  Adding Heparin to Aspirin Reduces the Incidence of Myocardial Infarction and Death in Patients With Unstable Angina: A Meta-analysis , 1996 .

[251]  P. Théroux,et al.  Platelet membrane receptor glycoprotein IIb/IIIa antagonism in unstable angina. The Canadian Lamifiban Study. , 1996, Circulation.

[252]  E. Antman.  Hirudin in acute myocardial infarction. Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9B trial. , 1996, Circulation.

[253]  G. Ciliberto,et al.  Elevated levels of interleukin-6 in unstable angina. , 1996, Circulation.

[254]  P. Collinson,et al.  Prospective study of the role of cardiac troponin T in patients admitted with unstable angina , 1996, BMJ.

[255]  K. Nakao,et al.  Nitric oxide activity is deficient in spasm arteries of patients with coronary spastic angina. , 1996, Circulation.

[256]  Robert L. Frye,et al.  Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. , 1996, The New England journal of medicine.

[257]  C. Cannon,et al.  Prognostic value of plasma fibrinogen concentration in patients with unstable angina and non-Q-wave myocardial infarction (TIMI IIIB Trial) , 1996, The American journal of cardiology.

[258]  J. Muhlestein,et al.  An emergency department-based protocol for rapidly ruling out myocardial ischemia reduces hospital time and expense: results of a randomized study (ROMIO). , 1996, Journal of the American College of Cardiology.

[259]  V. Rasmussen,et al.  Verapamil and angiotensin-converting enzyme inhibitors in patients with coronary artery disease and reduced left ventricular ejection fraction. , 1996, The American journal of cardiology.

[260]  P. Sleight,et al.  Fortnightly Review: Short acting dihydropyridine (vasodilating) calcium channel blockers for hypertension: is there a risk? , 1996 .

[261]  D. Ardissino,et al.  Thrombin activity and early outcome in unstable angina pectoris. , 1996, Circulation.

[262]  L. Wallentin,et al.  Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. The FRISC study group. , 1996, Circulation.

[263]  R. Califf,et al.  Long-term survival benefits of coronary artery bypass grafting and percutaneous transluminal angioplasty in patients with coronary artery disease. , 1996, The Journal of thoracic and cardiovascular surgery.

[264]  E. Braunwald,et al.  Influence of race, sex, and age on management of unstable angina and non-Q-wave myocardial infarction: The TIMI III registry. , 1996 .

[265]  C. Pepine.  Ergonovine echocardiography for coronary spasm: facts and wishful thinking. , 1996, Journal of the American College of Cardiology.

[266]  V. Gökhan Cin,et al.  The prognostic value of serum troponin T in unstable angina. , 1996, International journal of cardiology.

[267]  K. Lee,et al.  Activated partial thromboplastin time and outcome after thrombolytic therapy for acute myocardial infarction: results from the GUSTO-I trial. , 1996, Circulation.

[268]  R. Califf,et al.  Early discharge in the thrombolytic era: an analysis of criteria for uncomplicated infarction from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) trial. , 1996, Journal of the American College of Cardiology.

[269]  K. Fox,et al.  Early continuous ST segment monitoring in unstable angina: prognostic value additional to the clinical characteristics and the admission electrocardiogram. , 1996, Heart.

[270]  W. Boden,et al.  Coronary angiographic findings after non-Q-wave myocardial infarction: An analysis from the VANQWISH trial , 1996 .

[271]  P. Stone,et al.  Comparison of outcome of patients with unstable angina and non-Q-wave acute myocardial infarction with and without prior coronary artery bypass grafting (Thrombolysis in Myocardial Ischemia III Registry). , 1996, The American journal of cardiology.

[272]  Thomas W. Smith.  Cardiovascular therapeutics : a companion to Braunwald's heart disease , 1996 .

[273]  D. Clement.  A randomised, blinded, trial of Clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) , 1996 .

[274]  B. Rutherford,et al.  Results of direct percutaneous transluminal coronary angioplasty in octogenarians. , 1996, The American journal of cardiology.

[275]  L. Opie.  Calcium channel antagonists in the management of anginal syndromes: changing concepts in relation to the role of coronary vasospasm. , 1996, Progress in cardiovascular diseases.

[276]  Randall C. Thompson,et al.  Changing outcome of angioplasty in the elderly. , 1996, Journal of the American College of Cardiology.

[277]  C. Cannon,et al.  One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarction. , 1995, Journal of the American College of Cardiology.

[278]  P. Serruys,et al.  Fluctuation of spastic location in patients with vasospastic angina: a quantitative angiographic study. , 1995, Journal of the American College of Cardiology.

[279]  J. Ornato,et al.  American College of Emergency Physicians information paper: Chest pain units in emergency departments—A report from the short-term observation services section , 1995 .

[280]  J. Hollander.  The management of cocaine-associated myocardial ischemia. , 1995, The New England journal of medicine.

[281]  CABRI Trial Participants,et al.  First-year results of CABRI (Coronary Angioplasty versus Bypass Revascularisation Investigation) , 1995, The Lancet.

[282]  S. Pocock,et al.  Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgery , 1995, The Lancet.

[283]  Z. Rumboldt,et al.  Acute myocardial infarction in the young--the role of smoking. , 1995, European heart journal.

[284]  C. White,et al.  Unstable angina. A comparison of angioscopic findings between diabetic and nondiabetic patients. , 1995, Circulation.

[285]  G. Diamond,et al.  Comparison of the sensitivity and specificity of exercise electrocardiography in biased and unbiased populations of men and women. , 1995, American heart journal.

[286]  B. Chaitman,et al.  Treatment with bivalirudin (Hirulog) as compared with heparin during coronary angioplasty for unstable or postinfarction angina. Hirulog Angioplasty Study Investigators. , 1995, The New England journal of medicine.

[287]  P. Serruys,et al.  A comparison of hirudin with heparin in the prevention of restenosis after coronary angioplasty. Helvetica Investigators. , 1995, The New England journal of medicine.

[288]  J. Mair,et al.  Equivalent early sensitivities of myoglobin, creatine kinase MB mass, creatine kinase isoform ratios, and cardiac troponins I and T for acute myocardial infarction. , 1995, Clinical chemistry.

[289]  C. Cannon,et al.  Hirulog in the treatment of unstable angina. Results of the Thrombin Inhibition in Myocardial Ischemia (TIMI) 7 trial. , 1995, Circulation.

[290]  Wei Zhang,et al.  Prognostic efficacy of troponin T measurement in angina pectoris. , 1995, Chinese medical journal.

[291]  E. Gurfinkel,et al.  Low molecular weight heparin versus regular heparin or aspirin in the treatment of unstable angina and silent ischemia. , 1995, Journal of the American College of Cardiology.

[292]  J. Thomas,et al.  Exercise echocardiography is an accurate and cost-efficient technique for detection of coronary artery disease in women. , 1995, Journal of the American College of Cardiology.

[293]  J Herlitz,et al.  Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. , 1995, Journal of the American College of Cardiology.

[294]  E. Topol,et al.  Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine. , 1995, The New England journal of medicine.

[295]  C. Schultz,et al.  Management of Observation Units , 1995 .

[296]  W E Boden,et al.  Design of a placebo-controlled clinical trial of long-acting diltiazem and aspirin versus aspirin alone in patients receiving thrombolysis with a first acute myocardial infarction. Incomplete Infarction Trial of European Research Collaborators Evaluating Prognosis Post-Thrombolysis (diltiazem) (INTE , 1995, The American journal of cardiology.

[297]  R. Silverman,et al.  Cocaine-Associated Myocardial Infarction: Mortality and Complications , 1995 .

[298]  R. Hoffman,et al.  Cocaine-associated myocardial infarction. Mortality and complications. Cocaine-Associated Myocardial Infarction Study Group. , 1995, Archives of internal medicine.

[299]  J. Hirsh,et al.  Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. , 1995, The New England journal of medicine.

[300]  P. Bossuyt,et al.  Incidence and follow-up of Braunwald subgroups in unstable angina pectoris. , 1995, Journal of the American College of Cardiology.

[301]  L. Wallentin,et al.  Early diagnosis and exclusion of acute myocardial infarction using biochemical monitoring , 1995 .

[302]  R. Califf,et al.  Rebound increase in thrombin generation and activity after cessation of intravenous heparin in patients with acute coronary syndromes. , 1995, Circulation.

[303]  Raymond C. Schneider,et al.  ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction , 1995, The Lancet.

[304]  P A Poole-Wilson,et al.  Cardiac syndrome X: clinical characteristics and left ventricular function. Long-term follow-up study. , 1995, Journal of the American College of Cardiology.

[305]  Richard P. Lewis,et al.  Guidelines for clinical use of cardiac radionuclide imaging: A report of the American College of Cardiology/American Heart Association Task Force on assessment of diagnostic and therapeutic cardiovascular procedures (committee on radionuclide imaging) — Developed in collaboration with the American S , 1995, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[306]  M L Simoons,et al.  Pre-hospital triage of patients with suspected myocardial infarction. Evaluation of previously developed algorithms and new proposals. , 1995, European heart journal.

[307]  K. Thygesen,et al.  Independent prognostic value of serum creatine kinase isoenzyme MB mass, cardiac troponin T and myosin light chain levels in suspected acute myocardial infarction. Analysis of 28 months of follow-up in 196 patients. , 1995, Journal of the American College of Cardiology.

[308]  N. Frasure-smith,et al.  Depression and 18-month prognosis after myocardial infarction. , 1995, Circulation.

[309]  W. Weintraub,et al.  Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty. , 1995, Circulation.

[310]  Richard P. Lewis,et al.  Guidelines for clinical use of cardiac radionuclide imaging. Report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Radionuclide Imaging), developed in collaboration with the American Soci , 1995, Journal of the American College of Cardiology.

[311]  R. Myerburg,et al.  Cardiac complications of cocaine abuse , 1995, Clinical cardiology.

[312]  S. Palmeri,et al.  Coronary angioplasty in unstable angina: contemporary experience. , 1995, The Canadian journal of cardiology.

[313]  J. Lynch,et al.  Nonpeptide glycoprotein IIb/IIIa inhibitors. 5. Antithrombotic effects of MK-0383. , 1995, The Journal of pharmacology and experimental therapeutics.

[314]  R. Hoffman,et al.  Prospective multicenter evaluation of cocaine-associated chest pain. Cocaine Associated Chest Pain (COCHPA) Study Group. , 2008, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[315]  D. Pryor,et al.  Changes in Mortality after Myocardial Revascularization in the Elderly: The National Medicare Experience , 1994, Annals of Internal Medicine.

[316]  Scandinavian Simvastatin Survival Study Group.  Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) , 1994, The Lancet.

[317]  T. Kaul,et al.  Angioplasty versus coronary artery bypass in octogenarians. , 1994, The Annals of thoracic surgery.

[318]  S. Scott,et al.  VA Study of Unstable Angina. 10-year results show duration of surgical advantage for patients with impaired ejection fraction. , 1994, Circulation.

[319]  G. Lamas,et al.  Effects of captopril on ischemic events after myocardial infarction. Results of the Survival and Ventricular Enlargement trial. SAVE Investigators. , 1994, Circulation.

[320]  E. Antman.  Hirudin in acute myocardial infarction. Safety report from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9A Trial. , 1994, Circulation.

[321]  E. Braunwald,et al.  Clinical and arteriographic characterization of patients with unstable angina without critical coronary arterial narrowing (from the TIMI-IIIA Trial). , 1994, The American journal of cardiology.

[322]  J. Zimmerman,et al.  Use of a rapid assay of subforms of creatine kinase MB to diagnose or rule out acute myocardial infarction. , 1994, The New England journal of medicine.

[323]  R. Foale,et al.  Comparison of exercise echocardiography with an exercise score to diagnose coronary artery disease in women. , 1994, The American journal of cardiology.

[324]  J. Cruz,et al.  Outcome of patients with diabetes and unstable angina. A subgroup analysis in the Spanish Multicentre Trial of trifusal in unstable angina. Grupo de Estudio del Trifusal en la Angina Inestable. , 1994, International journal of cardiology.

[325]  T. Chalmers,et al.  Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration , 1994, The Lancet.

[326]  W. Weintraub,et al.  Percutaneous transluminal coronary angioplasty in patients aged > or = 90 years. , 1994, The American journal of cardiology.

[327]  Graves Ej.  Detailed diagnoses and procedures, National Hospital Discharge Survey, 1992. Series 13: Data from the National Health Survey. , 1994 .

[328]  H. Willens,et al.  Cardiovascular manifestations of cocaine abuse. A case of recurrent dilated cardiomyopathy. , 1994, Chest.

[329]  C. Simpfendorfer,et al.  Gender differences for coronary angioplasty. , 1994, American Journal of Cardiology.

[330]  N. Geller,et al.  Effects of treatment strategies to suppress ischemia in patients with coronary artery disease: 12-week results of the Asymptomatic Cardiac Ischemia Pilot (ACIP) study. , 1994, Journal of the American College of Cardiology.

[331]  W. Weintraub,et al.  Percutaneous transluminal coronary angioplasty in women compared with men. , 1994, Journal of the American College of Cardiology.

[332]  N. Geller,et al.  The Asymptomatic Cardiac Ischemia Pilot (ACIP) study: design of a randomized clinical trial, baseline data and implications for a long-term outcome trial. , 1994, Journal of the American College of Cardiology.

[333]  K. Fox,et al.  Comparison of the effect of heparin and aspirin versus aspirin alone on transient myocardial ischemia and in-hospital prognosis in patients with unstable angina. , 1994, Journal of the American College of Cardiology.

[334]  D. Tousoulis,et al.  Coronary Vasodilator Reserve, Pain Perception, and Sex in Patients With Syndrome X , 1994, Circulation.

[335]  A. Quyyumi,et al.  Imipramine in patients with chest pain despite normal coronary angiograms. , 1994, The New England journal of medicine.

[336]  R. Califf,et al.  Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six months , 1994, The Lancet.

[337]  K. Fox,et al.  Chest pain in women: clinical, investigative, and prognostic features , 1994, BMJ.

[338]  L. Shaw,et al.  Gender Differences in the Noninvasive Evaluation and Management of Patients with Suspected Coronary Artery Disease , 1994, Annals of Internal Medicine.

[339]  V. Fuster,et al.  Recombinant hirudin for unstable angina pectoris. A multicenter, randomized angiographic trial. , 1994, Circulation.

[340]  L. Wilkins.  Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia. , 1994, Circulation.

[341]  J. Hirshfeld,et al.  Comparison of results of intracoronary stenting in patients with unstable vs. stable angina. , 1994, Catheterization and cardiovascular diagnosis.

[342]  J. Koyama,et al.  Intravascular ultrasound detection of atherosclerosis at the site of focal vasospasm in angiographically normal or minimally narrowed coronary segments. , 1994, Journal of the American College of Cardiology.

[343]  N. Kleiman,et al.  Earlier diagnosis and treatment of acute myocardial infarction necessitates the need for a 'new diagnostic mind-set'. , 1994, Circulation.

[344]  Walker,et al.  Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients , 1994 .

[345]  J. Muller,et al.  Similar result of percutaneous transluminal coronary angioplasty for women and men with postmyocaedial infarction ischemia , 1994 .

[346]  E. Braunwald.  Unstable angina : diagnosis and management , 1994 .

[347]  E J Topol,et al.  Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: results at six months. The EPIC Investigators. , 1994, Lancet.

[348]  J. Muller,et al.  Similar results of percutaneous transluminal coronary angioplasty for women and men with postmyocardial infarction ischemia. , 1994, Journal of the American College of Cardiology.

[349]  L. Wilkins,et al.  National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). , 1994, Circulation.

[350]  R. Kronmal,et al.  Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users. Primary end points analysis from the ATACS trial. Antithrombotic Therapy in Acute Coronary Syndromes Research Group. , 1994, Circulation.

[351]  A. Takeshita,et al.  Role of coronary vasospasm in the pathogenesis of myocardial infarction: study in patients with no significant coronary stenosis. , 1993, American heart journal.

[352]  E. Jones,et al.  Changing Clinical Characteristics of Coronary Surgery Patients Differences Between Men and Women , 1993, Circulation.

[353]  P. Kopelman,et al.  Silent myocardial ischemia: role of subclinical neuropathy in patients with and without diabetes. , 1993, Journal of the American College of Cardiology.

[354]  D. Malenka,et al.  Differences between men and women in hospital mortality associated with coronary artery bypass graft surgery. The Northern New England Cardiovascular Disease Study Group. , 1993, Circulation.

[355]  J. Ravkilde,et al.  Diagnostic performance and prognostic value of serum troponin T in suspected acute myocardial infarction. , 1993, Scandinavian journal of clinical and laboratory investigation.

[356]  S. Rahimtoola,et al.  Survival at 15 to 18 Years After Coronary Bypass Surgery for Angina in Women , 1993, Circulation.

[357]  D. Waters,et al.  Aspirin Versus Heparin to Prevent Myocardial Infarction During the Acute Phase of Unstable Angina , 1993, Circulation.

[358]  Randall C. Thompson,et al.  Predicting Early and Intermediate‐Term Outcome of Coronary Angioplast in the Elderly , 1993, Circulation.

[359]  P. Kudenchuk,et al.  Prehospital-initiated vs hospital-initiated thrombolytic therapy. The Myocardial Infarction Triage and Intervention Trial. , 1993, JAMA.

[360]  L. Wallentin,et al.  Very early risk stratification by electrocardiogram at rest in men with suspected unstable coronary heart disease , 1993, Journal of internal medicine.

[361]  C. Bass,et al.  Psychosocial outcome and use of medical resources in patients with chest pain and normal or near-normal coronary arteries: a long-term follow-up study. , 1993, The Quarterly journal of medicine.

[362]  A. Jaffe,et al.  Biochemical Markers of Myocardial Injury Is MB Creatine Kinase the Choice for the 1990s? , 1993, Circulation.

[363]  A. Distante,et al.  Efficacy of isosorbide-5-mononitrate versus nifedipine in preventing spontaneous and ergonovine-induced myocardial ischaemia. A double-blind, placebo-controlled study. , 1993, European heart journal.

[364]  L. Hillis,et al.  Influence of labetalol on cocaine-induced coronary vasoconstriction in humans. , 1993, The American journal of medicine.

[365]  J. Herlitz,et al.  One‐year prognosis in patients hospitalized with a history of unstable angina pectoris , 1993, Clinical cardiology.

[366]  K. Bailey,et al.  The changing in-hospital mortality of women undergoing percutaneous transluminal coronary angioplasty. , 1993, JAMA.

[367]  F. Loop,et al.  The effect of coronary reoperation on the survival of patients with stenoses in saphenous vein bypass grafts to coronary arteries. , 1993, The Journal of thoracic and cardiovascular surgery.

[368]  R. Macalpin,et al.  Cardiac arrest and sudden unexpected death in variant angina: complications of coronary spasm that can occur in the absence of severe organic coronary stenosis. , 1993, American heart journal.

[369]  P. Altieri,et al.  Cocaine induced myocardial ischemia. , 1993, Puerto Rico health sciences journal.

[370]  R. Cooper,et al.  Delay between onset of chest pain and arrival to the coronary care unit among minority and disadvantaged patients. , 1993, Journal of the National Medical Association.

[371]  S. Kelsey,et al.  Results of percutaneous transluminal coronary angioplasty in women. 1985-1986 National Heart, Lung, and Blood Institute's Coronary Angioplasty Registry. , 1993, Circulation.

[372]  Robert Califf,et al.  Value of the History and Physical in Identifying Patients at Increased Risk for Coronary Artery Disease , 1993, Annals of Internal Medicine.

[373]  R. Diaz,et al.  Significance of Smoking in Patients Receiving Thrombolytic Therapy for Acute Myocardial Infarction Experience Gleaned From the International Tissue Plasminogen Activator/Streptokinase Mortality Trial , 1993, Circulation.

[374]  F. Takatsu,et al.  Cigarette Smoking Is a Major Risk Factor for Coronary Spasm , 1993, Circulation.

[375]  W. Vermaak,et al.  Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemia. , 1993, The American journal of clinical nutrition.

[376]  K. Schrör.  The basic pharmacology of ticlopidine and clopidogrel. , 1993, Platelets.

[377]  T. Giles,et al.  Randomized placebo-controlled trial of amlodipine in vasospastic angina. Amlodipine Study 160 Group. , 1993, Journal of the American College of Cardiology.

[378]  B. Pitt,et al.  Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions , 1992, The Lancet.

[379]  J. Gold,et al.  Survival Analysis of Octogenarian Patients With Coronary Artery Disease Managed by Elective Coronary Artery Bypass Surgery Versus Conventional Medical Treatment , 1992, Circulation.

[380]  W. White,et al.  Performance status and outcome after coronary artery bypass grafting in persons aged 80 to 93 years. , 1992, The American journal of cardiology.

[381]  W. Willett,et al.  A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. , 1992, JAMA.

[382]  H. Katus,et al.  The prognostic value of serum troponin T in unstable angina. , 1992, The New England journal of medicine.

[383]  D. Waters,et al.  Reactivation of unstable angina after the discontinuation of heparin. , 1992, The New England journal of medicine.

[384]  T. Nakamura,et al.  Statistical analysis of clinical risk factors for coronary artery spasm: identification of the most important determinant. , 1992, American Heart Journal.

[385]  J. L. Willems,et al.  Immediate and follow-up results of the conservative coronary angioplasty strategy for unstable angina pectoris. , 1992, The American journal of cardiology.

[386]  D. Lasorda,et al.  Extraction atherectomy during myocardial infarction in a patient with prior coronary artery bypass surgery. , 1992, Catheterization and cardiovascular diagnosis.

[387]  R B D'Agostino,et al.  Do patients' coronary risk factor reports predict acute cardiac ischemia in the emergency department? A multicenter study. , 1992, Journal of clinical epidemiology.

[388]  F. Loop,et al.  Vein graft disease: the clinical impact of stenoses in saphenous vein bypass grafts to coronary arteries. , 1992, The Journal of thoracic and cardiovascular surgery.

[389]  E. Hannan,et al.  Gender differences in mortality rates for coronary artery bypass surgery. , 1992, American heart journal.

[390]  R. Cannon,et al.  Pathophysiological dilemma of syndrome X. , 1992, Circulation.

[391]  L. Wallentin,et al.  The predictive value of silent ischemia at an exercise test before discharge after an episode of unstable coronary artery disease. RISC Study Group. , 1992, American heart journal.

[392]  R. Kloner,et al.  The effects of acute and chronic cocaine use on the heart. , 1992, Circulation.

[393]  S. Khuri,et al.  Coronary bypass surgery improves survival in high-risk unstable angina. Results of a Veterans Administration Cooperative study with an 8-year follow-up. Veterans Administration Unstable Angina Cooperative Study Group. , 1991, Circulation.

[394]  J. Shepherd,et al.  Endothelium‐Derived Vasoactive Factors: I Endothelium‐Dependent Relaxation , 1991, Hypertension.

[395]  J. T. Shepherd,et al.  Endothelium‐Derived Vasoactive Factors: II Endothelium‐Dependent Contraction , 1991, Hypertension.

[396]  L. Cohn,et al.  ACC/AHA guidelines for cardiac catheterization and cardiac catheterization laboratories. American College of Cardiology/American Heart Association Ad Hoc Task Force on Cardiac Catheterization. , 1991, Circulation.

[397]  A. Jaffe,et al.  Relation between ST segment shifts during ischemia and thrombin activity in patients with unstable angina. , 1991, Journal of the American College of Cardiology.

[398]  F. Harrell,et al.  Prognostic value of a treadmill exercise score in outpatients with suspected coronary artery disease. , 1991, The New England journal of medicine.

[399]  K. Allman,et al.  Prognostic significance of a predischarge exercise test in risk stratification after unstable angina pectoris. , 1991, Journal of the American College of Cardiology.

[400]  S. Goldsmith,et al.  Cocaine and chest pain: clinical features and outcome of patients hospitalized to rule out myocardial infarction. , 1991, Annals of internal medicine.

[401]  Fesmire Fm,et al.  Diagnostic and prognostic importance of comparing the initial to the previous electrocardiogram in patients admitted for suspected acute myocardial infarction. , 1991 .

[402]  H. Schaff,et al.  Cardiac surgery in the octogenarian: perioperative outcome and clinical follow-up. , 1991, Journal of the American College of Cardiology.

[403]  Harry P. Selker,et al.  A Tool for Judging Coronary Care Unit Admission Appropriateness, Valid for Both Real-Time and Retrospective Use: A Time-Insensitive Predictive Instrument (TIPI) for Acute Cardiac Ischemia: A Multicenter Study , 1991, Medical care.

[404]  E. Ferrannini,et al.  Coronary hemodynamics and myocardial metabolism in patients with syndrome X: response to pacing stress. , 1991, Journal of the American College of Cardiology.

[405]  E F Cook,et al.  Ruling out acute myocardial infarction. A prospective multicenter validation of a 12-hour strategy for patients at low risk. , 1991, The New England journal of medicine.

[406]  J. Melin,et al.  Logistic Discriminant Analysis Improves Diagnostic Accuracy of Exercise Testing for Coronary Artery Disease in Women , 1991, Circulation.

[407]  Graves Ej,et al.  Detailed diagnoses and procedures, National Hospital Discharge Survey, 1994. , 1997, Vital and health statistics. Series 13, Data from the National Health Survey.

[408]  P. Puddu,et al.  Angiographic morphology in unstable angina and its relation to transient myocardial ischemia and hospital outcome. , 1991, The American journal of cardiology.

[409]  R. Lidón,et al.  Rebound myocardial ischaemia following abrupt interruption of intravenous nitroglycerin infusion in patients with unstable angina at rest. , 1991, European heart journal.

[410]  A. Ellis.  Serum protein measurements and the diagnosis of acute myocardial infarction. , 1991, Circulation.

[411]  Standards of Medical Care for Patients With Diabetes Mellitus , 1991, Diabetes Care.

[412]  L. Hillis,et al.  Alleviation of cocaine-induced coronary vasoconstriction by nitroglycerin. , 1991, Journal of the American College of Cardiology.

[413]  J. Isner,et al.  Cardiovascular complications of cocaine. , 1991, Current problems in cardiology.

[414]  E. Jones,et al.  Coronary bypass surgery: is the operation different today? , 1991, The Journal of thoracic and cardiovascular surgery.

[415]  D. Waters,et al.  Unstable angina: special considerations in the postbypass patient. , 1991, Cardiovascular clinics.

[416]  Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. , 1991, JAMA.

[417]  V. Fuster,et al.  Usefulness of antithrombotic therapy in resting angina pectoris or non-Q-wave myocardial infarction in preventing death and myocardial infarction (a pilot study from the Antithrombotic Therapy in Acute Coronary Syndromes Study Group). , 1990, The American journal of cardiology.

[418]  P. Armstrong,et al.  Relation of angiographic detected intracoronary thrombus and silent myocardial ischemia in unstable angina pectoris. , 1990, The American journal of cardiology.

[419]  M. Hwang,et al.  Progression of native coronary artery disease at 10 years: insights from a randomized study of medical versus surgical therapy for angina. , 1990, Journal of the American College of Cardiology.

[420]  The Risc Group.  Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease , 1990, The Lancet.

[421]  W. L. Ooi,et al.  Prevalence, incidence and prognosis of recognized and unrecognized myocardial infarction in persons aged 75 years or older: The Bronx Aging Study. , 1990, The American journal of cardiology.

[422]  W. Wijns,et al.  Reversal of segmental hypokinesis by coronary angioplasty in patients with unstable angina, persistent T wave inversion, and left anterior descending coronary artery stenosis. Additional evidence for myocardial stunning in humans. , 1990, Circulation.

[423]  L. Hillis,et al.  Effect of cocaine on coronary artery dimensions in atherosclerotic coronary artery disease: enhanced vasoconstriction at sites of significant stenoses. , 1990, Journal of the American College of Cardiology.

[424]  C. Cimminiello,et al.  Antiplatelet treatment with ticlopidine in unstable angina. A controlled multicenter clinical trial. The Studio della Ticlopidina nell'Angina Instabile Group. , 1990, Circulation.

[425]  L. Hillis,et al.  Potentiation of cocaine-induced coronary vasoconstriction by beta-adrenergic blockade. , 1990, Annals of internal medicine.

[426]  W. Laskey,et al.  Influence of heparin therapy on percutaneous transluminal coronary angioplasty outcome in unstable angina pectoris. , 1990, The American journal of cardiology.

[427]  R. Abbate,et al.  Effect of heparin, aspirin, or alteplase in reduction of myocardial ischaemia in refractory unstable angina , 1990, The Lancet.

[428]  W. Roberts,et al.  Quantitative analysis of amounts of coronary arterial narrowing in cocaine addicts. , 1990, The American journal of cardiology.

[429]  P. D. Chapman,et al.  Prehospital prophylactic lidocaine does not favorably affect outcome in patients with chest pain. , 1989, Annals of emergency medicine.

[430]  D. Carden,et al.  An evaluation of cocaine-induced chest pain. , 1989, Annals of emergency medicine.

[431]  M. Swash,et al.  Exertional myocardial ischemia in diabetes: a quantitative analysis of anginal perceptual threshold and the influence of autonomic function. , 1990, Journal of the American College of Cardiology.

[432]  N. Pandian,et al.  Reversible cardiomyopathy associated with cocaine intoxication. , 1989, Annals of internal medicine.

[433]  J. Isner,et al.  Cocaine and vasospasm. , 1989, The New England journal of medicine.

[434]  C. Yancy,et al.  Cocaine-induced coronary-artery vasoconstriction. , 1989, The New England journal of medicine.

[435]  K. Nademanee,et al.  Myocardial ischemia during cocaine withdrawal. , 1989, Annals of internal medicine.

[436]  K. Okumura,et al.  Circadian variation of plasma fibrinopeptide A level in patients with variant angina. , 1989, Circulation.

[437]  G. Schuler,et al.  Four-year follow-up study in patients with angina pectoris and normal coronary arteriograms ("syndrome X") , 1989, Circulation.

[438]  E. Cook,et al.  Clinical characteristics and outcome of acute myocardial infarction in patients with initially normal or nonspecific electrocardiograms (a report from the Multicenter Chest Pain Study). , 1989, The American journal of cardiology.

[439]  C. Furberg,et al.  Calcium channel blockers in acute myocardial infarction and unstable angina: an overview. , 1989, BMJ.

[440]  S. Khuri,et al.  Medical compared with surgical management of unstable angina. 5-year mortality and morbidity in the Veterans Administration Study. , 1989, Circulation.

[441]  R. Kleiger,et al.  Risk stratification of patients with non-Q wave myocardial infarction. The critical role of ST segment depression. The Diltiazem Reinfarction Study Research Group. , 1989, Circulation.

[442]  D. Faxon,et al.  One-year follow-up results of the 1985-1986 National Heart, Lung, and Blood Institute's Percutaneous Transluminal Coronary Angioplasty Registry. , 1989, Circulation.

[443]  R. Vestal,et al.  Management of drug therapy in the elderly. , 1989, The New England journal of medicine.

[444]  F. Crea,et al.  Lack of evidence for alpha-adrenergic receptor-mediated mechanisms in the genesis of ischemia in syndrome X. , 1989, The American journal of cardiology.

[445]  E. Braunwald,et al.  Unstable angina. A classification. , 1989, Circulation.

[446]  N. Mekhail,et al.  Cocaine-induced small vessel spasm in isolated rat hearts. , 1989, The American journal of pathology.

[447]  P. Armstrong,et al.  ST segment shift in unstable angina: pathophysiology and association with coronary anatomy and hospital outcome. , 1989, Journal of the American College of Cardiology.

[448]  K. Loper.  Clinical Toxicology of Cocaine , 1989, Medical toxicology and adverse drug experience.

[449]  M. Winniford,et al.  Simultaneous acute thrombosis of two major coronary arteries following intravenous cocaine use. , 1989, Archives of pathology & laboratory medicine.

[450]  Rotterdam,et al.  Short-, medium-, and long-term follow-up after percutaneous transluminal coronary angioplasty for stable and unstable angina pectoris. , 1989, American heart journal.

[451]  L. Campeau,et al.  Preoperative and operative predictive variables of late clinical events following saphenous vein coronary artery bypass graft surgery. , 1989, The Canadian journal of cardiology.

[452]  W. Dassen,et al.  Angiographic and clinical characteristics of patients with unstable angina showing an ECG pattern indicating critical narrowing of the proximal LAD coronary artery. , 1989, American heart journal.

[453]  P. Puddu,et al.  Comparison of verapamil versus propranolol therapy in syndrome X. , 1989, The American journal of cardiology.

[454]  D. Ardissino,et al.  Hyperventilation and ergonovine tests in Prinzmetal's variant angina pectoris in men. , 1989, The American journal of cardiology.

[455]  A. Lovinfosse.  [Care "objectives"]. , 1989, FNIB info.

[456]  Theresa M. Beckie,et al.  A supportive-educative telephone program: impact on knowledge and anxiety after coronary artery bypass graft surgery. , 1989, Heart & lung : the journal of critical care.

[457]  A. Seth,et al.  Coronary angioplasty in unstable angina and stable angina: a comparison of success and complications. , 1988, British heart journal.

[458]  P. Théroux,et al.  Aspirin, heparin, or both to treat acute unstable angina. , 1988, The New England journal of medicine.

[459]  J. Wittes,et al.  Overview of results of randomized clinical trials in heart disease. II. Unstable angina, heart failure, primary prevention with aspirin, and risk factor modification. , 1988, JAMA.

[460]  S. Scott,et al.  Veterans Administration Cooperative Study for treatment of patients with unstable angina. Results in patients with abnormal left ventricular function. , 1988, Circulation.

[461]  T. Ryan.  Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). , 1988, Journal of the American College of Cardiology.

[462]  M. Horie,et al.  Long-term prognosis for patients with variant angina and influential factors. , 1988, Circulation.

[463]  S. Goldman,et al.  Cocaine and cardiovascular function in dogs: effects on heart and peripheral circulation. , 1988, Journal of the American College of Cardiology.

[464]  H P Selker,et al.  How Did the Acute Ischemic Heart Disease Predictiue Instrument Reduce Unnecessary Coronary Care Unit Admissions? , 1988, Medical decision making : an international journal of the Society for Medical Decision Making.

[465]  B. Gersh,et al.  Comparison of effects of medical and surgical therapy on survival in severe angina pectoris and two-vessel coronary artery disease with and without left ventricular dysfunction: a Coronary Artery Surgery Study Registry Study. , 1988, The American journal of cardiology.

[466]  R. Collins,et al.  EFFECT OF INTRAVENOUS NITRATES ON MORTALITY IN ACUTE MYOCARDIAL INFARCTION: AN OVERVIEW OF THE RANDOMISED TRIALS , 1988, The Lancet.

[467]  R. Virmani,et al.  Cardiovascular effects of cocaine: an autopsy study of 40 patients. , 1988, American heart journal.

[468]  E F Cook,et al.  A computer protocol to predict myocardial infarction in emergency department patients with chest pain. , 1988, The New England journal of medicine.

[469]  F. Harrell,et al.  Importance of clinical measures of ischemia in the prognosis of patients with documented coronary artery disease. , 1988, Journal of the American College of Cardiology.

[470]  D. Waters,et al.  Long-term prognosis of patients with variant angina. , 1987, Circulation.

[471]  M A Hlatky,et al.  Outcome in suspected acute myocardial infarction with normal or minimally abnormal admission electrocardiographic findings. , 1987, The American journal of cardiology.

[472]  J. Lubsen,et al.  Efficacy of nifedipine and metoprolol in the early treatment of unstable angina in the coronary care unit: findings from the Holland Interuniversity Nifedipine/metoprolol Trial (HINT). , 1987, The American journal of cardiology.

[473]  S. Scott,et al.  Comparison of medical and surgical treatment for unstable angina pectoris. Results of a Veterans Administration Cooperative Study. , 1987, The New England journal of medicine.

[474]  H. Kemp,et al.  Recurrent myocardial infarction associated with cocaine abuse in a young man with normal coronary arteries: evidence for coronary artery spasm culminating in thrombosis. , 1987, Journal of the American College of Cardiology.

[475]  D. Baim,et al.  Usefulness of percutaneous transluminal coronary angioplasty for unstable angina pectoris after non-Q-wave acute myocardial infarction. , 1987, The American journal of cardiology.

[476]  J. Lubsen,et al.  Nifedipine and Metoprolol in Unstable Angina: Findings from the Holland Interuniversity Nifedipine/Metoprolol Trial (HINT) , 1987, Journal of cardiovascular pharmacology.

[477]  J. Barboriak,et al.  Atherosclerosis in aortocoronary bypass grafts. Morphologic study and risk factor analysis 6 to 12 years after surgery. , 1986, Arteriosclerosis.

[478]  K. Kugiyama,et al.  Induction of coronary artery spasm by acetylcholine in patients with variant angina: possible role of the parasympathetic nervous system in the pathogenesis of coronary artery spasm. , 1986, Circulation.

[479]  D. Waters,et al.  Previous coronary artery bypass grafting as an adverse prognostic factor in unstable angina pectoris. , 1986, The American journal of cardiology.

[480]  R. Kleiger,et al.  Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction. Results of a double-blind, randomized, multicenter trial. , 1986, The New England journal of medicine.

[481]  J. Hofsteenge,et al.  Kinetics of the inhibition of thrombin by hirudin. , 1986, Biochemistry.

[482]  M. Winniford,et al.  Speculation regarding mechanisms responsible for acute ischemic heart disease syndromes. , 1986, Journal of the American College of Cardiology.

[483]  A. Vinik,et al.  Abnormal cardiac function in diabetic patients with autonomic neuropathy in the absence of ischemic heart disease. , 1986, The Journal of clinical endocrinology and metabolism.

[484]  P. Serruys,et al.  Coronary angioplasty of the unstable angina related vessel in patients with multivessel disease. , 1986, European heart journal.

[485]  C. Lenfant,et al.  National High Blood Pressure Education Program. , 1986, Journal of the American Optometric Association.

[486]  R. Kronmal,et al.  Seven year survival of patients with normal or near normal coronary arteriograms: a CASS registry study. , 1986, Journal of the American College of Cardiology.

[487]  D. Williams,et al.  Anticoagulant treatment in unstable angina , 1986, The British journal of clinical practice.

[488]  Vasilomanolakis Ec.  Geriatric cardiology: when exercise stress testing is justified. , 1985, Geriatrics.

[489]  D. Sackett,et al.  Aspirin, sulfinpyrazone, or both in unstable angina. Results of a Canadian multicenter trial. , 1985, The New England journal of medicine.

[490]  H. Sox,et al.  Clinical prediction rules. Applications and methodological standards. , 1985, The New England journal of medicine.

[491]  R. Cannon,et al.  Efficacy of calcium channel blocker therapy for angina pectoris resulting from small-vessel coronary artery disease and abnormal vasodilator reserve. , 1985, The American journal of cardiology.

[492]  R. A. Johnson,et al.  Prognostic value of a coronary artery jeopardy score. , 1985, Journal of the American College of Cardiology.

[493]  W. Wijns,et al.  Alternative diagnostic strategies for coronary artery disease in women: demonstration of the usefulness and efficiency of probability analysis. , 1985, Circulation.

[494]  E F Cook,et al.  Acute chest pain in the emergency room. Identification and examination of low-risk patients. , 1985, Archives of internal medicine.

[495]  L. Caprino,et al.  Platelet responsiveness and biosynthesis of thromboxane and prostacyclin in response to in vitro cocaine treatment. , 1985, Haemostasis.

[496]  E. Vasilomanolakis.  Geriatric cardiology: when exercise stress testing is justified. , 1985, Geriatrics.

[497]  S. Kelsey,et al.  Sex differences in early and long-term results of coronary angioplasty in the NHLBI PTCA Registry. , 1985, Circulation.

[498]  T. Ulbright,et al.  Morphologic observations after percutaneous transluminal balloon angioplasty of early and late aortocoronary saphenous vein bypass grafts. , 1984, Journal of the American College of Cardiology.

[499]  M. Bourassa,et al.  Comparison of late changes in internal mammary artery and saphenous vein grafts in two consecutive series of patients 10 years after operation. , 1984, Circulation.

[500]  R B D'Agostino,et al.  A predictive instrument to improve coronary-care-unit admission practices in acute ischemic heart disease. A prospective multicenter clinical trial. , 1984, The New England journal of medicine.

[501]  Eleven-year survival in the Veterans Administration randomized trial of coronary bypass surgery for stable angina. , 1984, The New England journal of medicine.

[502]  F. Harrell,et al.  Estimating the likelihood of significant coronary artery disease. , 1983, The American journal of medicine.

[503]  Lippincott Williams Wilkins,et al.  Coronary artery surgery study (CASS): a randomized trial of coronary artery bypass surgery. Survival data. , 1983, Circulation.

[504]  M. Matsuzaki,et al.  Coronary arteriography and left ventriculography during spontaneous and exercise-induced ST segment elevation in patients with variant angina. , 1983, American heart journal.

[505]  M. LeWinter,et al.  Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study. , 1983, The New England journal of medicine.

[506]  R. Mulcahy,et al.  Long term effect on mortality of stopping smoking after unstable angina and myocardial infarction. , 1983, British medical journal.

[507]  D. Haines,et al.  Anatomic and prognostic significance of new T-wave inversion in unstable angina. , 1983, The American journal of cardiology.

[508]  S. Rahimtoola,et al.  Ten-year survival after coronary bypass surgery for unstable angina. , 1983, The New England journal of medicine.

[509]  L. Karp.  A definition of terms , 1983 .

[510]  W. C. Sheldon,et al.  Coronary artery surgery in women compared with men: analyses of risks and long-term results. , 1983, Journal of the American College of Cardiology.

[511]  G. Lawrie,et al.  The Influence of Residual Disease After Coronary Bypass on the 5‐year Survival Rate of 1274 Men with Coronary Artery Disease , 1982, Circulation.

[512]  Jeffrey A. Stem,et al.  A computer-derived protocol to aid in the diagnosis of emergency room patients with acute chest pain. , 1982, The New England journal of medicine.

[513]  J. W. Kennedy,et al.  Association of sex, physical size, and operative mortality after coronary artery bypass in the Coronary Artery Surgery Study (CASS). , 1982, The Journal of thoracic and cardiovascular surgery.

[514]  D. Waters,et al.  Clinical Characteristics Associated with Sudden Death in Patients with Variant Angina , 1982, Circulation.

[515]  H. Sustaita,et al.  Ruptured Atheromatous Plaques in Saphenous Vein Coronary Artery Bypass Grafts: A Mechanism of Acute, Thrombotic, Late Graft Occlusion , 1982, Circulation.

[516]  W. Rogers,et al.  Angiographic Prevalence of High‐risk Coronary Artery Disease in Patient Subsets (CASS) , 1981, Circulation.

[517]  A. Telford,et al.  TRIAL OF HEPARIN VERSUS ATENOLOL IN PREVENTION OF MYOCARDIAL INFARCTION IN INTERMEDIATE CORONARY SYNDROME , 1981, The Lancet.

[518]  R. O'rourke,et al.  Treadmill exercise tests predischarge and six weeks post-myocardial infarction to detect abnormalities of known prognostic value. , 1981, Annals of internal medicine.

[519]  S. Tsung.  Several conditions causing elevation of serum CK-MB and CK-BB. , 1981, American journal of clinical pathology.

[520]  S. Marra,et al.  Sudden occlusion of a saphenous vein bypass graft relieved by direct injection of nitroglycerin. , 1981, Catheterization and cardiovascular diagnosis.

[521]  R. Miller,et al.  Provocation of Coronary Artery Spasm by the Cold Pressor Test: Hemodynamic, Arteriographic and Quantitative Angiographic Observations , 1980, Circulation.

[522]  D. Waters,et al.  Previously Undiagnosed Variant Angina as a Cause of Chest Pain after Coronary Artery Bypass Surgery , 1980, Circulation.

[523]  S. Chierchia,et al.  "Variant" angina: one aspect of a continuous spectrum of vasospastic myocardial ischemia. Pathogenetic mechanisms, estimated incidence and clinical and coronary arteriographic findings in 138 patients. , 1978, The American journal of cardiology.

[524]  J. Ehrhardt,et al.  Thallium-201 myocardial perfusion scintigrams in the evaluation of aorto-coronary saphenous bypass surgery. , 1978, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[525]  J. Ritchie,et al.  Thallium‐201 Myocardial Imaging Before and After Coronary Revascularization: Assessment of Regional Myocardial Blood Flow and Graft Patency , 1977, Circulation.

[526]  A. Maseri,et al.  CORONARY VASOSPASM IN ANGINA PECTORIS , 1977, The Lancet.

[527]  M. Lipton,et al.  The VA cooperative randomized study of surgery for coronary arterial occlusive disease II. Subgroup with significant left main lesions. , 1976, Circulation.

[528]  H. Yasue,et al.  Prinzmetal's variant form of angina as a manifestation of alpha-adrenergic receptor-mediated coronary artery spasm: documentation by coronary arteriography. , 1976, American heart journal.

[529]  B. Hopkinson.  Angina pectoris--II. , 1971, British medical journal.

[530]  R. Bruce,et al.  Comparative Effects of Aging and Coronary Heart Disease on Submaximal and Maximal Exercise , 1969, Circulation.

[531]  M. Prinzmetal,et al.  Angina pectoris. II. Observations on the classic form of angina pectoris; preliminary report. , 1959, American heart journal.